Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.6990
+0.0119 (1.72%)
Sep 12, 2025, 3:57 PM EDT
Elite Pharmaceuticals Revenue
Elite Pharmaceuticals had revenue of $40.21M in the quarter ending June 30, 2025, with 113.85% growth. This brings the company's revenue in the last twelve months to $105.45M, up 58.70% year-over-year. In the fiscal year ending March 31, 2025, Elite Pharmaceuticals had annual revenue of $84.04M with 48.42% growth.
Revenue (ttm)
105.45M
Revenue Growth
+58.70%
P/S Ratio
7.11
Revenue / Employee
1.55M
Employees
68
Market Cap
750.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 84.04M | 27.42M | 48.42% |
| Mar 31, 2024 | 56.63M | 22.47M | 65.79% |
| Mar 31, 2023 | 34.16M | 1.89M | 5.87% |
| Mar 31, 2022 | 32.26M | 6.88M | 27.11% |
| Mar 31, 2021 | 25.38M | 7.39M | 41.05% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 2.12M |
| Glass House Brands | 221.55M |
| Northwest Biotherapeutics | 1.09M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.17M |
| AMJ Global Technology | 39.00 |
| Global Cord Blood | 196.10M |
Elite Pharmaceuticals News
- 4 weeks ago - Elite Pharmaceuticals Inc (ELTP) Q1 2026 Earnings Call Highlights: Revenue Surge and Strategic ... - GuruFocus
- 4 weeks ago - Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M - Seeking Alpha
- 4 weeks ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2026 ended June 30, 2025 and Provides Conference Call Information - Newsfile Corp
- 5 weeks ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2026 Financial Results on August 15, 2025 - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals, Inc. (ELTP) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Elite Pharmaceuticals reports FY results - Seeking Alpha
- 2 months ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2025 and Provides Conference Call Information - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2025 Financial Results on July 1, 2025 - Newsfile Corp